Role of L-Arginine Supplementation in the Treatment of Rheumatoid Arthritis
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Rheumatoid Arthritis
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Participant)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 45 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04535427
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Xiaoxiang Chen, PhD Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine